C.R. Bard, Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha (Free subscription) | 07/24/2008
CR Bard Inc (BCR) Q2 FY08 Earnings Call Complete Story »
- add comment
- send to a friend
- Explore : China
Seeking Alpha (Free subscription) | 07/24/2008
CR Bard Inc (BCR) Q2 FY08 Earnings Call Complete Story »
Jim Cramer's Mad Money (Free subscription) | 07/14/2008
Jim Cramer’s Mad Money Stock Picks for Friday July 11 2008. These are all of Jim Cramer’s stock picks that are a Buy! I bold my picks. Buy: CR Bard (BCR) Genentech (DNA) Eaton (ETN) Johnson & Johnson (JNJ) Coca-Cola (KO) PPG Industries (PPG) Yum! Brands (YUM) Sell: Advanced Micro Devices (AMD) Natus Medical (BABY) CIENA Corp (CIEN) Continental Resources (CLR) Fannie Mae (FNM) Freddie Mac (FRE) Intel...
World of stocks (Free subscription) | 07/12/2008
TheStreet.com Booyah! Newsletter Cramer's 'Mad Money' Recap: CR Bard Takes Center Stage Fannie, Freddie Take Down Wall Street With Them 7/11/2008 1:51 PM EDT Fannie, Freddie Continue to Falter (Update2) 7/11/2008 10:04 AM EDT AMD Hit With Another Huge Writedown 7/11/2008 12:58 PM EDT Infosys Plunges on Cautious Outlook Bangalore-based Infosys Technologies fell Friday after the company issued cautious...
The Street (Free subscription) | 07/12/2008
The company has a flourishing business in stents, catheters and other medical devices, Cramer says.
Market Watch (Free subscription) | 06/11/2008
SAN FRANCISCO (MarketWatch) -- C.R. Bard Inc. said late Wednesday its board increased the quarterly dividend by 7% to 16 cents. The dividend is payable Aug. 1 to shareholders of record as of July 21. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
GuruFocus Updates (Free subscription) | 05/09/2008
Richard Aster Jr reduced to his holdings in Medical Supplies company C.R. Bard Inc. (BCR) during the 3-months ended 2008-03-31 by 20.21%. His sale prices were between $ 90.42 and $ 99.51, with an estimated average price of $ 95.3. The impact to his portfolio due to this sale was 1.61 %. His still held 574587 shares as of 2008-03-31. As of last market close, the price of C.R. Bard Inc. (BCR) was $ 92.19....
Seeking Alpha (Free subscription) | 04/24/2008
C. R. Bard, Inc. (BCR) Q1 FY08 Earnings Call Complete Story »
Market Watch (Free subscription) | 04/23/2008
SAN FRANCISCO (MarketWatch) -- C.R. Bard Inc. late Wednesday reported its first-quarter net income slid to $78 million, or 76 cents a share, from $101.6 million, or 98 cents a share, a year earlier. Income from continuing operations was $78 million, or 76 cents a share. Revenue increased to $584 million from $528.2 million, said the Murray Hill, N.J.-based health care products company. Market Pulse...
Seeking Alpha (Free subscription) | 04/22/2008
C. R. Bard, Inc. (BCR) Q4 FY07 Earnings Call Complete Story »
The Street (Free subscription) | 04/11/2008
Companies such as C.R. Bard and Becton Dickinson might not be the most glamorous names, but their slow and steady performances may win the race.
Deseret Morning News (Free subscription) | 03/14/2008
C.R. Bard Inc. this week agreed to acquire all the outstanding shares of Specialized Health Products International Inc., based in Bountiful.
Market Watch (Free subscription) | 12/12/2007
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
Jim Cramer's Mad Money (Free subscription) | 11/16/2007
Jim Cramers Mad Money Stock Picks for Thursday November 15 2007. These are all of Jim Cramer’s stock picks that are a Buy! I bold my picks. Buy: Aecom Technology (ACM) Baxter International Inc (BAX) CR Bard Inc (BCR) Becton Dickinson & Co (BDX) Chicago Bridge & Iron Co NV (CBI) Costco Wholesale Corp (COST) EMC Corp (EMC) Foster Wheeler Ltd (FWLT) Hologic Inc (HOLX) Inverness [...]
Medgadget (Free subscription) | 11/09/2007
The FDA has approved the sale of C.R. Bard's new Agento™ silver coated endotracheal tube. The company, though, is awaiting publication of results of a peer reviewed clinical trial of the device in one of the major medical journals, before putting the product on the market. C.R. Bard is keeping somewhat tight lipped about the Agento™, and told Medgadget they will wait to start marketing the device before...
Seeking Alpha (Free subscription) | 10/24/2007
Ladies and gentlemen, thank you very much for standing by and welcome to the C. R. Bard Incorporated Third Quarter 2007 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. And later, we will conduct a question-and-answer session. Instructions will be given at that time. (Operator Instructions).